Jul 2 |
Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices
|
Jul 2 |
Alzheimer’s Disease Treatments: What to Know About New and Future Drugs
|
Jul 2 |
Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
|
Jul 2 |
Eli Lilly Gets FDA Approval for Alzheimer's Disease Drug
|
Jul 2 |
Biden, Sanders call for obesity drug makers to cut prices
|
Jul 2 |
Sector Update: Health Care Stocks Softer Late Afternoon
|
Jul 2 |
Fighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
|
Jul 2 |
FDA approves Eli Lilly's Alzheimer's drug Kisunla
|
Jul 2 |
FDA Approves Eli Lilly’s Alzheimer’s Drug
|
Jul 2 |
Approval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment
|